Eaglenos Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 220

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $22M

  • Investors
  • 6

Eaglenos General Information

Description

Manufacturer of diagnostic devices designed to provide portable and precise health monitoring. The company's technology utilizes electrochemical sensing and microfluidics to offer blood gas biochemical analyzers, electrolyte analyzers, blood glucose meters, uric acid test strips, continuous glucose monitoring devices, and scanning electrochemical cell microscopes, enabling healthcare institutions and home users to access laboratory-grade diagnostic results through compact, maintenance-free systems.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building B2-2
  • Number 73 Tanmi Road, Jiangbei New District
  • Nanjing, Jiangsu 210000
  • China
+86 400
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Corporate Office
  • Building B2-2
  • Number 73 Tanmi Road, Jiangbei New District
  • Nanjing, Jiangsu 210000
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eaglenos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC (Series A) 24-Feb-2023 $22M Completed Generating Revenue
To view Eaglenos’s complete valuation and funding history, request access »

Eaglenos Patents

Eaglenos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025214327-A1 Dry film self-calibration sensing device and method for measuring concentration of analyte by dry film self-calibration sensing device Pending 12-Apr-2024
WO-2025118453-A1 Composite enzyme solution for total cholesterol detection, test paper and detection system Inactive 08-Dec-2023
JP-2026534675-A Inserter, implantable analyte monitoring device, and implantable analyte monitoring system Pending 20-Nov-2023
AU-2024386634-A1 Needle-assisting device, implantable analyte monitoring device, and implantable analyte monitoring system Pending 20-Nov-2023
EP-4767935-A1 Needle-assisting device, implantable analyte monitoring device, and implantable analyte monitoring system Pending 20-Nov-2023 A61B5/14532
To view Eaglenos’s complete patent history, request access »

Eaglenos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eaglenos Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
3E Bioventures Capital Venture Capital Minority
3E Bioventures (China) Venture Capital Minority
Grand Yangtze Capital Venture Capital Minority
Huatai Zijin Investment Corporate Venture Capital Minority
InnoMed Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Eaglenos Acquisitions (1)

Eaglenos’s most recent deal was a Merger/Acquisition with Novlead Biotech for . The deal was made on 06-Mar-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Novlead Biotech 06-Mar-2019 Merger/Acquisition Therapeutic Devices
To view Eaglenos’s complete acquisitions history, request access »

Eaglenos FAQs

  • When was Eaglenos founded?

    Eaglenos was founded in 2017.

  • Where is Eaglenos headquartered?

    Eaglenos is headquartered in Nanjing, China.

  • What is the size of Eaglenos?

    Eaglenos has 220 total employees.

  • What industry is Eaglenos in?

    Eaglenos’s primary industry is Diagnostic Equipment.

  • Is Eaglenos a private or public company?

    Eaglenos is a Private company.

  • What is the current valuation of Eaglenos?

    The current valuation of Eaglenos is .

  • What is Eaglenos’s current revenue?

    The current revenue for Eaglenos is .

  • How much funding has Eaglenos raised over time?

    Eaglenos has raised $22M.

  • Who are Eaglenos’s investors?

    3E Bioventures Capital, 3E Bioventures (China), Grand Yangtze Capital, Huatai Zijin Investment, and InnoMed Capital are 5 of 6 investors who have invested in Eaglenos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process